cbdMD (YCBD) Non Operating Investment Income (2017 - 2023)
cbdMD (YCBD) reported Non Operating Investment Income of -$700000.0 for Q3 2023, down 35000100.0% on a YoY basis from N/an in Q3 2022, and down 35000100.0% sequentially from $2.0 in Q3 2022.
cbdMD (YCBD) Non Operating Investment Income (2017 - 2023) Analysis & Trends
cbdMD (YCBD) has 4 years of Non Operating Investment Income data on file, last reported at -$700000.0 in Q3 2023.
- For the quarter ending Q3 2023, Non Operating Investment Income fell 35000100.0% year-over-year to -$700000.0; the trailing twelve-month figure through Sep 2023 stood at -$700000.0 (down 1999.01% YoY), and the FY2023 full-year result was -$700000.0, down 1998.95% from the prior year.
- Non Operating Investment Income retreated to -$700000.0 in Q3 2023, from $2.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $19938.0 in Q3 2021 to a low of -$700000.0 in Q3 2023.
- A 3-year average of -$146406.8 and a median of -$18623.0 in 2021 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income tumbled 99.99% in 2022 and sank 35000100.0% in 2023, its largest moves.
- Tracing YCBD's Non Operating Investment Income over 3 years: stood at -$33351.0 in 2021, then soared by 100.01% to $2.0 in 2022, then slumped by 35000100.0% to -$700000.0 in 2023.
- Business Quant data shows YCBD's Non Operating Investment Income at -$700000.0 in Q3 2023, $2.0 in Q3 2022, and -$33351.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | cbdMD | 4.82 Mn | 1.43 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -700,000.00 |
| Sep 30, 2023 | -700,000.00 |
| Sep 30, 2022 | 2.00 |
| Sep 30, 2022 | 2.00 |
| Dec 31, 2021 | -33,351.00 |
| Dec 31, 2021 | -33,351.00 |
| Sep 30, 2021 | 19,938.00 |
| Sep 30, 2021 | 19,938.00 |
| Jun 30, 2021 | -18,623.00 |
| Jun 30, 2021 | -18,623.00 |
| Dec 31, 2017 | 33,500.00 |
| Dec 31, 2017 | 33,500.00 |